Medicus Pharma Ltd (MDCX)

$3.03 -0.27 (-8.18%)
Market Cap 44.79M
Revenue (ttm) 0.00
Net Income (ttm) -11.16M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 751,000
Avg Vol 407,230
Day's Range N/A - N/A
Shares Out 13.57M
Stochastic %K 30%
Beta N/A
Analysts Strong Sell
Price Target $16.15

Company Profile

Medicus Pharma Ltd., a biotech/life sciences company, focuses on developing clinical development programs of therapeutic assets. It develops SkinJect for the treatment of basal cell carcinoma. The company was founded in 2015 and is headquartered in Toronto, Canada.

Industry: Drug Manufacturers - General
Sector: Healthcare
Address:
One First Canadian Place, Suite 3400 100 King Street West, Toronto, Canada
2TrustHim
2TrustHim Jul. 11 at 11:02 PM
$MDCX YOU LOAD UP!!!
0 · Reply
bullrider19
bullrider19 Jul. 11 at 3:12 PM
$MDCX no sell you buy
1 · Reply
Mjcwo
Mjcwo Jul. 11 at 2:59 PM
$CMPS $DDOG $GLMD $MDCX $MU solid positions taken in these for mid term gains.
0 · Reply
bullrider19
bullrider19 Jul. 11 at 2:41 PM
$MDCX BUY BUY BUY $$$$$$CLOSE@ $5.13 today
0 · Reply
Canadianinvestor01
Canadianinvestor01 Jul. 11 at 2:07 PM
$MDCX It looks like I was wright about that stock distribution to new bagholders all pumpers and so called analyst are gone and volume is drying up. Just another pump and dump from crooks but that (try) to pump was very weak .
0 · Reply
bullrider19
bullrider19 Jul. 10 at 1:33 PM
$MDCX HOLD or BUY BUY BUY $$$$$
0 · Reply
bullrider19
bullrider19 Jul. 10 at 11:09 AM
$MDCX 2-3% daily rise with trade gap closing
0 · Reply
smash2020
smash2020 Jul. 10 at 4:56 AM
$MDCX why did it drop from 9 to 3?
1 · Reply
GoCubsGo1124
GoCubsGo1124 Jul. 9 at 10:59 PM
$MDCX anyone here because they smashed that ravishing like button and took the ultimate risk for the ultimate frisk? 😉😉
1 · Reply
0dte_Gambler
0dte_Gambler Jul. 9 at 9:04 PM
$MDCX What happened in the end of May to drop the stock from $8 to $2.50?
1 · Reply
Latest News on MDCX
Medicus Pharma Ltd. Announces Submission of Type C Meeting Request to the Food and Drug Administration (FDA)

Jul 8, 2025, 7:30 AM EDT - 4 days ago

Medicus Pharma Ltd. Announces Submission of Type C Meeting Request to the Food and Drug Administration (FDA)

Medicus Pharma: High-Risk But Higher Reward For Their Potential Breakthrough Skin Cancer Treatment

Jul 4, 2025, 9:49 AM EDT - 8 days ago

Medicus Pharma: High-Risk But Higher Reward For Their Potential Breakthrough Skin Cancer Treatment

Medicus Pharma Ltd Announces a Definitive Agreement to Acquire Antev Ltd. UK

Jun 30, 2025, 7:30 AM EDT - 12 days ago

Medicus Pharma Ltd Announces a Definitive Agreement to Acquire Antev Ltd. UK

Medicus Pharma Ltd. Announces Appointment of Andrew Smith as Chief Operating Officer

Jun 23, 2025, 7:30 AM EDT - 19 days ago

Medicus Pharma Ltd. Announces Appointment of Andrew Smith as Chief Operating Officer

Medicus Pharma Ltd. to Present at 2025 Bio International Convention

Jun 12, 2025, 7:30 AM EDT - 4 weeks ago

Medicus Pharma Ltd. to Present at 2025 Bio International Convention

Medicus Pharma Ltd. Announces Submission of Product Development Plan to the Food and Drug Administration (FDA) to Treat External Squamous Cell Carcinoma (SCC) in Horses

Jun 9, 2025, 7:30 AM EDT - 4 weeks ago

Medicus Pharma Ltd. Announces Submission of Product Development Plan to the Food and Drug Administration (FDA) to Treat External Squamous Cell Carcinoma (SCC) in Horses

Medicus Pharma Ltd. Announces Closing of $7.0 Million Public Offering

Jun 2, 2025, 1:40 PM EDT - 5 weeks ago

Medicus Pharma Ltd. Announces Closing of $7.0 Million Public Offering

Medicus Pharma Ltd. Announces Pricing of $7.0 Million Public Offering

May 29, 2025, 8:30 PM EDT - 6 weeks ago

Medicus Pharma Ltd. Announces Pricing of $7.0 Million Public Offering

Medicus Pharma Ltd Receives Study May Proceed Approval from United Arab Emirates (UAE) Department of Health (DOH) to Commence Phase 2 Clinical Study (SKNJCT-004) to Non-Invasively Treat Basal Cell Carcinoma of the Skin (BCC)

May 22, 2025, 7:30 AM EDT - 7 weeks ago

Medicus Pharma Ltd Receives Study May Proceed Approval from United Arab Emirates (UAE) Department of Health (DOH) to Commence Phase 2 Clinical Study (SKNJCT-004) to Non-Invasively Treat Basal Cell Carcinoma of the Skin (BCC)

Medicus Pharma's 'Savvy' Antev Deal De-Risks Pipeline Expansion, Enhances Near-Commercial Portfolio

May 12, 2025, 2:20 PM EDT - 2 months ago

Medicus Pharma's 'Savvy' Antev Deal De-Risks Pipeline Expansion, Enhances Near-Commercial Portfolio

Medicus Pharma Ltd. Announces a Binding Letter of Intent to Acquire Antev Ltd.

Apr 28, 2025, 7:30 AM EDT - 2 months ago

Medicus Pharma Ltd. Announces a Binding Letter of Intent to Acquire Antev Ltd.

Medicus Pharma Provides Update on SKNJCT-003 Phase 2 Clinical Study for the Treatment of Nodular Basal Cell Carcinoma (BCC)

Apr 21, 2025, 7:30 AM EDT - 2 months ago

Medicus Pharma Provides Update on SKNJCT-003 Phase 2 Clinical Study for the Treatment of Nodular Basal Cell Carcinoma (BCC)

Medicus Pharma Ltd. Announces Closing of $4.2 Million Regulation A Offering

Mar 10, 2025, 4:05 PM EDT - 4 months ago

Medicus Pharma Ltd. Announces Closing of $4.2 Million Regulation A Offering

Medicus Pharma Ltd. Announces Pricing of $4.2 Million Regulation A Offering

Mar 6, 2025, 8:30 PM EST - 4 months ago

Medicus Pharma Ltd. Announces Pricing of $4.2 Million Regulation A Offering

Medicus Pharma Ltd Announces Positively Trending Interim Analysis for SKNJCT-003 Phase 2 Clinical Study to Non-Invasively Treat Basal Cell Carcinoma of the Skin (BCC)

Mar 6, 2025, 7:30 AM EST - 4 months ago

Medicus Pharma Ltd Announces Positively Trending Interim Analysis for SKNJCT-003 Phase 2 Clinical Study to Non-Invasively Treat Basal Cell Carcinoma of the Skin (BCC)

Medicus Pharma Ltd Announces Submission of Phase 2 Clinical Design (SKNJCT-004) to United Arab Emirates (UAE) Department of Health (DOH) to Non-Invasively Treat Basal Cell Carcinoma of the Skin (BCC)

Feb 27, 2025, 7:30 AM EST - 4 months ago

Medicus Pharma Ltd Announces Submission of Phase 2 Clinical Design (SKNJCT-004) to United Arab Emirates (UAE) Department of Health (DOH) to Non-Invasively Treat Basal Cell Carcinoma of the Skin (BCC)

Medicus Pharma Ltd. Enters into Standby Equity Purchase Agreement and Announces Intention to Voluntarily Delist from the TSX Venture Exchange (TSXV)

Feb 11, 2025, 7:41 AM EST - 5 months ago

Medicus Pharma Ltd. Enters into Standby Equity Purchase Agreement and Announces Intention to Voluntarily Delist from the TSX Venture Exchange (TSXV)

Medicus Pharma Ltd. Announces Minor Use (MUMS) Designation from the FDA for Doxorubicin-Containing Microneedle Array (D-MNA) Patch

Dec 12, 2024, 7:30 AM EST - 7 months ago

Medicus Pharma Ltd. Announces Minor Use (MUMS) Designation from the FDA for Doxorubicin-Containing Microneedle Array (D-MNA) Patch

Medicus Pharma Ltd. Announces Collaboration Agreement to Expand Phase 2 Clinical Study in Asia Pacific Region

Dec 2, 2024, 7:30 AM EST - 7 months ago

Medicus Pharma Ltd. Announces Collaboration Agreement to Expand Phase 2 Clinical Study in Asia Pacific Region

Medicus Pharma Ltd. Appoints Faisal Mehmud, MD, MRCP as Chief Medical Officer

Nov 18, 2024, 7:30 AM EST - 8 months ago

Medicus Pharma Ltd. Appoints Faisal Mehmud, MD, MRCP as Chief Medical Officer

Medicus Pharma Ltd. Announces Closing of US$4.0M Initial Public Offering in the United States

Nov 15, 2024, 4:47 PM EST - 8 months ago

Medicus Pharma Ltd. Announces Closing of US$4.0M Initial Public Offering in the United States

Medicus Pharma Ltd. Announces Pricing of US$4.0M Initial Public Offering in the United States

Nov 13, 2024, 6:45 PM EST - 8 months ago

Medicus Pharma Ltd. Announces Pricing of US$4.0M Initial Public Offering in the United States

2TrustHim
2TrustHim Jul. 11 at 11:02 PM
$MDCX YOU LOAD UP!!!
0 · Reply
bullrider19
bullrider19 Jul. 11 at 3:12 PM
$MDCX no sell you buy
1 · Reply
Mjcwo
Mjcwo Jul. 11 at 2:59 PM
$CMPS $DDOG $GLMD $MDCX $MU solid positions taken in these for mid term gains.
0 · Reply
bullrider19
bullrider19 Jul. 11 at 2:41 PM
$MDCX BUY BUY BUY $$$$$$CLOSE@ $5.13 today
0 · Reply
Canadianinvestor01
Canadianinvestor01 Jul. 11 at 2:07 PM
$MDCX It looks like I was wright about that stock distribution to new bagholders all pumpers and so called analyst are gone and volume is drying up. Just another pump and dump from crooks but that (try) to pump was very weak .
0 · Reply
bullrider19
bullrider19 Jul. 10 at 1:33 PM
$MDCX HOLD or BUY BUY BUY $$$$$
0 · Reply
bullrider19
bullrider19 Jul. 10 at 11:09 AM
$MDCX 2-3% daily rise with trade gap closing
0 · Reply
smash2020
smash2020 Jul. 10 at 4:56 AM
$MDCX why did it drop from 9 to 3?
1 · Reply
GoCubsGo1124
GoCubsGo1124 Jul. 9 at 10:59 PM
$MDCX anyone here because they smashed that ravishing like button and took the ultimate risk for the ultimate frisk? 😉😉
1 · Reply
0dte_Gambler
0dte_Gambler Jul. 9 at 9:04 PM
$MDCX What happened in the end of May to drop the stock from $8 to $2.50?
1 · Reply
thebusthebus
thebusthebus Jul. 9 at 8:15 PM
$MDCX Talked to somebody that works in a dermatology office today. They said if this product works, it will be a game changer. I started a small position, add overtime.
0 · Reply
Cryvantis
Cryvantis Jul. 9 at 7:50 PM
$MDCX WKSP on radar! July dealer sales +42% YoY, repeat orders landing 10 days early. Q3 may pull forward nearly a quarter of revenue 📈 Float <5M shares. One upside surprise and this could rerate fast. Watching $5.50 resistance 👀
1 · Reply
bullrider19
bullrider19 Jul. 9 at 4:17 PM
$MDCX its 11ish buy buy buy
0 · Reply
ForkMAN
ForkMAN Jul. 9 at 3:27 PM
$MDCX I wonder if this will push to sit above VWAP?
0 · Reply
ForkMAN
ForkMAN Jul. 9 at 2:29 PM
$MDCX Def some larger $$ interest at these levels.
0 · Reply
Mjcwo
Mjcwo Jul. 9 at 1:47 PM
$GLMD $MDCX everyone here is early….congrats, keep buying.
0 · Reply
bullrider19
bullrider19 Jul. 9 at 1:09 PM
$MDCX start buy back around 11am
0 · Reply
JarvisFlow
JarvisFlow Jul. 9 at 1:00 PM
D. Boral Capital has updated their rating for Medicus Pharma ( $MDCX ) to Buy with a price target of 27.
1 · Reply
DARKP00L
DARKP00L Jul. 9 at 12:56 PM
$MDCX 08:55 on Jul. 09 2025 D. Boral Capital Maintains Buy on Medicus Pharma, Maintains $27 Price Target #tradeideas
0 · Reply
2TrustHim
2TrustHim Jul. 9 at 12:20 PM
$MDCX Somebody wanted in. I saw a 15,000 share bid possibly change from $3.33 to $3.38 and it went through and is almost finished with $9,000 shares left!!!
0 · Reply
bullrider19
bullrider19 Jul. 9 at 11:59 AM
$MDCX take profit early $$$ buy back more shares soon after open
0 · Reply
Love_To_Learn
Love_To_Learn Jul. 9 at 11:20 AM
$MDCX creeping u up using the scalp cycles of mbio and bmgl for now
0 · Reply